Summary

This article presents 1-year data from the Durable Polymer-Based Stent Challenge of Promus Element Versus Resolute Integrity in an All Comers Population [DUTCH PEERS (TWENTE II); von Birgelen C et al. Lancet 2013 (epublished ahead of print)] study. The results demonstrated comparable clinical outcomes with zotarolimus-eluting stents and everolimus-eluting stents (EES); both are third-generation, permanent, polymer-based, drug-eluting stents. There was no significant difference in efficacy and safety between the two stents, and longitudinal stent deformation was only seen in the EES group.